Compare CVS Health Corp (CVS) vs Howmet Aerospace Inc (HWM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Howmet Aerospace Inc — how do they compare? CVS Health Corp trades at $86.07 (market cap $112.29B), while Howmet Aerospace Inc trades at $225.14 (market cap $88.76B). The key difference: CVS Health Corp is the larger of the two by market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Howmet Aerospace Inc for 35 Days on average.
| CVS | HWM | |
|---|---|---|
Market Cap | $112.29B | $88.76B |
Volume | 7,763,676 | 2,648,516 |
Sector | Health | Industrials |
52-Week High | $110.60 | $292.65 |
52-Week Low | $70.08 | $184.09 |
Typical Hold Time | 83 Days | 35 Days |
Enterprise Value | $174.64B | $92.86B |
Dividend Yield | 3.03% | 0.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
Howmet Aerospace (HWM) trades at $225.50, up 1.26% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains robust fundamentals with 20.52% net income margin and 34.89% ROE. Recent news highlights defense aerospace demand driving revenue growth, while institutional interest remains strong with Nykredit's $44.69 million investment in Q2 2026.
Outlook remains positive with 84% analyst buy ratings and $328.10 consensus price target suggesting 45% upside. Key risks include supply chain pressures and competitive threats from SpaceX's in-house initiatives. Earnings growth and defense contracts position HWM for sustained performance despite near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Howmet Aerospace Inc
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →
